JP2024543347A5 - - Google Patents
Info
- Publication number
- JP2024543347A5 JP2024543347A5 JP2024526916A JP2024526916A JP2024543347A5 JP 2024543347 A5 JP2024543347 A5 JP 2024543347A5 JP 2024526916 A JP2024526916 A JP 2024526916A JP 2024526916 A JP2024526916 A JP 2024526916A JP 2024543347 A5 JP2024543347 A5 JP 2024543347A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- treatment
- patient
- fasudil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278523P | 2021-11-12 | 2021-11-12 | |
| US63/278,523 | 2021-11-12 | ||
| PCT/US2022/049541 WO2023086468A1 (en) | 2021-11-12 | 2022-11-10 | Method of treating amyotrophic lateral sclerosis and dosing regimen for same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543347A JP2024543347A (ja) | 2024-11-21 |
| JP2024543347A5 true JP2024543347A5 (https=) | 2025-11-12 |
Family
ID=86336738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526916A Pending JP2024543347A (ja) | 2021-11-12 | 2022-11-10 | 筋萎縮性側索硬化症を治療する方法およびそれに対する投与計画 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240415846A1 (https=) |
| EP (1) | EP4429667A4 (https=) |
| JP (1) | JP2024543347A (https=) |
| CN (1) | CN118251226A (https=) |
| CA (1) | CA3236338A1 (https=) |
| MX (1) | MX2024005745A (https=) |
| WO (1) | WO2023086468A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025207476A1 (en) * | 2024-03-25 | 2025-10-02 | Woolsey Pharmaceuticals, Inc. | Methods for treating als with a rho kinase inhibitor based on use of neurofilament light chain biomarker |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007050783A2 (en) * | 2005-10-26 | 2007-05-03 | Asahi Kasei Pharma Corporation | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| US9980972B2 (en) * | 2012-03-12 | 2018-05-29 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Rho kinase inhibitors for use in treating familial amyotrophic lateral sclerosis |
| US20180055887A1 (en) * | 2016-08-23 | 2018-03-01 | Academia Sinica | Method for preparing induced mesenchymal stem cells and improving mesenchymal stem cell's characters and its applications |
| US11642352B2 (en) * | 2020-03-25 | 2023-05-09 | Woolsey Pharmaceuticals, Inc. | Methods of treating wandering in Lewy dody dementia |
-
2022
- 2022-11-10 CN CN202280074805.3A patent/CN118251226A/zh active Pending
- 2022-11-10 WO PCT/US2022/049541 patent/WO2023086468A1/en not_active Ceased
- 2022-11-10 EP EP22893607.6A patent/EP4429667A4/en active Pending
- 2022-11-10 MX MX2024005745A patent/MX2024005745A/es unknown
- 2022-11-10 JP JP2024526916A patent/JP2024543347A/ja active Pending
- 2022-11-10 CA CA3236338A patent/CA3236338A1/en active Pending
- 2022-11-10 US US18/700,424 patent/US20240415846A1/en active Pending